Neucore Bio, an early-stage biotechnology company advancing the therapeutic potential of non-viral, engineered exosomes, announced today the receipt of a $304,000 U.S. National Science Foundation (NSF ...
The Chosun Ilbo on MSN
U.S. NDAA Bio Security Act Benefits Korean Biotech
The U.S. Congress is set to pass the National Defense Authorization Act (NDAA), which includes key provisions of the proposed ...
Neucore Bio Inc. has received a $350,000 STTR phase I grant from the National Center for Advancing Translational Sciences (NCATS) at the U.S. National Institutes of Health (NIH) to evaluate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback